EUVIMEDEUVIMED entdecken
Crossref

Using anti‐PD‐L1 antibody conjugated gold nanoshelled poly ( Lactic‐co‐glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer

Hui Jiang, Yingying Zhou, Dongdong Zheng iD, Yexiazi Cheng, Dacheng Xiang, Lixin Jiang, Jing Du iD

Journal of Biomedical Materials Research Part A · 2024

DOI: 10.1002/jbm.a.37638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Hui Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Nanocapsules, Triple Negative Breast Neoplasms, Nanoparticles, Glycolates. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Joint Research Project of Health and Family Planning of Shanghai Pudong New Area Health Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple negative breast cancer (TNBC) has the worst prognosis of all breast cancers, and it is difficult to progress through traditional chemotherapy. Therefore, the treatment of TNBC urgently requires agents with effective diagnostic and therapeutic capabilities. In this study, we obtained programmed death‐ligand 1 (PD‐L1) antibody conjugated gold nanoshelled poly(lactic‐co‐glycolic acid) (PLGA) nanocapsules (NCs) encapsulating doxorubicin (DOX) (DOX@PLGA@Au‐PD‐L1 NCs). PLGA NCs encapsulating DOX were prepared by a modified single‐emulsion oil‐in‐water (O/W) solvent evaporation method, and gold nanoshells were formed on the surface by gold seed growth method, which were coupled with PD‐L1 antibodies by carbodiimide method. The fabricated DOX@PLGA@Au‐PD‐L1 NCs exhibited promising contrast enhancement in vitro ultrasound imaging. Furthermore, DOX encapsulated in NCs displayed good pH‐responsive and photo‐triggered drug release properties. After irradiating 200 μg/mL NCs solution with a laser for 10 min, the solution temperature increased by nearly 23°C, indicating that the NCs had good photothermal conversion ability. The targeting experiments confirmed that the NCs had specific target binding ability to TNBC cells overexpressing PD‐L1 molecules. Cell experiments exhibited that the agent significantly reduced the survival rate of TNBC cells through photochemotherapy combination therapy. As a multifunctional diagnostic agent, DOX@PLGA@Au‐PD‐L1 NCs could be used for ultrasound targeted contrast imaging and photochemotherapy combination therapy of TNBC cells, providing a promising idea for early diagnosis and treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanocapsulesTriple Negative Breast NeoplasmsNanoparticlesGlycolatesHumansGlycolsPrecision MedicineGoldB7-H1 AntigenDoxorubicinUltrasonographyCell Line, Tumor

Stichwörter der Autor:innen

anti-PD-L1 antibodygold nanoparticlesphotochemotherapytriple negative breast cancerultrasound imaging

Substanzen

NanocapsulesGlycolsGoldB7-H1 Antigenglycolic acidDoxorubicinGlycolates

Autor:innen und Institutionen

  • Department of Ultrasound, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Ultrasound, Zhabei Central Hospital, Shanghai, P. R. China.
  • Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
  • College of Chemistry and Materials Science, Shanghai Normal University, Shanghai, P. R. China.

ORCID-Profile: Dongdong Zheng, Jing Du

Förderung

  • National Natural Science Foundation of China
  • The Joint Research Project of Health and Family Planning of Shanghai Pudong New Area Health Committee

Zitieren

APA

Jiang, H., Zhou, Y., Zheng, D., Cheng, Y., Xiang, D., Jiang, L., & Du, J. (2024). Using anti‐PD‐L1 antibody conjugated gold nanoshelled poly ( Lactic‐co‐glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37638

Vancouver

Jiang H, Zhou Y, Zheng D, Cheng Y, Xiang D, Jiang L, et al. Using anti‐PD‐L1 antibody conjugated gold nanoshelled poly ( Lactic‐co‐glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37638

BibTeX
@article{Jiang2024,
  author = {Jiang, Hui and Zhou, Yingying and Zheng, Dongdong and Cheng, Yexiazi and Xiang, Dacheng and Jiang, Lixin and Du, Jing},
  title = {Using anti‐PD‐L1 antibody conjugated gold nanoshelled poly ( Lactic‐co‐glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2024},
  doi = {10.1002/jbm.a.37638}
}
Kostenlos starten →